Penumbra, Inc. (PEN) - Long-Term Liabilities to Capital

This daily price chart for Penumbra, Inc. (PEN) reflects metrics at the level of 0.11. The therapeutic device manufacturer is implementing eco-friendly sterilization methods and replacing plastic with cardboard. The business focuses on developing clot removal systems while optimizing water consumption at its plants. The success of Penumbra, Inc. (PEN) relies on the synergy between physicians and engineers who create neurovascular solutions to combat strokes.

Steady cash flow from clot removal systems allows Penumbra, Inc. (PEN) to expand without excessive debt leverage. The long-term debt-to-equity ratio reflects the proportion of liabilities with maturities exceeding one year relative to shareholders' equity, where low values confirm financial stability and minimize default risks, which investors perceive as a sign of high operational reliability.